US Chapter

A

• Abbott Laboratories
  
• Adverse Drug Reaction
  
• Adverse event
  
• Almirall Prodesfarma
  
• Amgen
  
• Approved drugs
  
• Assay sensitivity
  
• AstraZeneca
  

B

• Bayer AG
  
• Biogen Idec
  
• Biopharmaceutical networking
  
• Boehringer-Ingelheim Pharmaceuticals
  

C

• Case Report Form
  
• Clinical Trials Budgeting
  
• Clinical baseline
  
• Clinical investigator
  
• Clinical monitoring
  
• Clinical protocol
  
• Clinical research
  
• Clinical research associate
  
• Clinical research nurse
  
• Clinical site
  
• Clinical study design
  
• Clinical trial
  
• Clinical trial management
  
• Confidentiality agreement
  
• Contract research organization
  
• Contract research organizations
  
• Covered clinical study
  

D

• Double-blind
  
• Drug
  
• Drug design
  
• Drug discovery
  

E

• Effect size
  
• Exclusion criteria
  

F

• Food and Drug Administration
  

G

• Genentech
  
• GlaxoSmithKline
  
• Good Manufacturing Practice
  
• Good clinical practice
  

I

• Inclusion criteria
  
• Informed consent
  
• Institute for OneWorld Health
  
• Institutional review board
  
• International Conference on Harmonisation
  
• Investigational product
  
• Investigator's Brochure
  

K

• Kriger Research Center
  

L

• Life-threatening
  
• List of contract research organizations
  
• List of pharmaceutical companies
  

M

• Merck & Co.
  
• Multicenter trial
  

N

• Nonclinical studies
  
• Novartis
  

P

• Patent
  
• Pharmaceutical company
  
• Pharmaceutical project
  
• Pharmacology
  
• Placebo
  
• Placebo effect
  

Q

• Quality system
  

R

• Randomized controlled trial
  
• Regulatory requirement
  

S

• Safety monitoring
  
• Serious adverse event
  
• Serono
  
• Standard Operating Procedures
  
• Standard treatment
  
• Study population
  

T

• Teva Pharmaceutical Industries, Ltd.